SMTI vs. BVS

Last updated Jun 3, 2026

SMTI (Sanara MedTech Inc.) and BVS (Bioventus Inc.) are both stocks. Both are in the Healthcare sector — SMTI in Medical Instruments & Supplies, BVS in Medical Devices. Over the past 5 years, SMTI returned -6.59%/yr vs -14.50%/yr for BVS. At a 0.21 correlation, their price movements are largely independent.

Performance

SMTI vs. BVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sanara MedTech Inc. (SMTI) and Bioventus Inc. (BVS). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, SMTI achieves a -8.95% return, which is significantly lower than BVS's 9.01% return.

SMTI

• 1D: -3.01%
• 1M: 7.75%
• YTD: -8.95%
• 6M: 5.25%
• 1Y: -26.92%
• 3Y*: -17.01%
• 5Y*: -6.59%
• 10Y*: 14.07%

BVS

• 1D: 2.27%
• 1M: -19.78%
• YTD: 9.01%
• 6M: 7.28%
• 1Y: 25.93%
• 3Y*: 39.93%
• 5Y*: -14.50%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

SMTI vs. BVS - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
SMTI Sanara MedTech Inc.	-8.95%	-29.67%	-19.22%	-9.67%	53.98%	-27.93%
BVS Bioventus Inc.	9.01%	-29.14%	99.24%	101.92%	-81.99%	-24.57%

Correlation

The correlation between SMTI and BVS is 0.42, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.42
Correlation (3Y) Calculated over the trailing 3-year period	0.28
Correlation (5Y) Calculated over the trailing 5-year period	0.22
Correlation (All Time) Calculated using the full available price history since Feb 12, 2021	0.21

Over the past year, SMTI and BVS have become more correlated (0.42) than their long-term average of 0.21, meaning their price movements have been converging.

Fundamentals

Market Cap SMTI : $191.04M BVS : $567.77M
EPS SMTI : -$3.82 BVS : $0.41
PS Ratio SMTI : 1.74 BVS : 0.97
PB Ratio SMTI : 27.18 BVS : 3.01
Total Revenue (TTM) SMTI : $107.48M BVS : $576.30M
Gross Profit (TTM) SMTI : $97.21M BVS : $390.14M
EBITDA (TTM) SMTI : $16.13M BVS : $98.72M

Return for Risk

SMTI vs. BVS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SMTI

SMTI Risk / Return Rank: 23
SMTI Sharpe Ratio Rank: 21
SMTI Sortino Ratio Rank: 23
SMTI Omega Ratio Rank: 23
SMTI Calmar Ratio Rank: 24
SMTI Martin Ratio Rank: 24

BVS

BVS Risk / Return Rank: 59
BVS Sharpe Ratio Rank: 58
BVS Sortino Ratio Rank: 56
BVS Omega Ratio Rank: 55
BVS Calmar Ratio Rank: 59
BVS Martin Ratio Rank: 68

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SMTI vs. BVS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sanara MedTech Inc. (SMTI) and Bioventus Inc. (BVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	SMTI	BVS	Difference
Sharpe ratio Return per unit of total volatility	-0.44	0.52	-0.96
Sortino ratio Return per unit of downside risk	-0.30	1.14	-1.43
Omega ratio Gain probability vs. loss probability	0.96	1.14	-0.17
Calmar ratio Return relative to maximum drawdown	-0.49	0.91	-1.41
Martin ratio Return relative to average drawdown	-0.83	3.41	-4.24
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

SMTI vs. BVS - Sharpe Ratio Comparison

The current SMTI Sharpe Ratio is -0.44, which is lower than the BVS Sharpe Ratio of 0.52. The chart below compares the historical Sharpe Ratios of SMTI and BVS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	SMTI	BVS	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.44	0.52	-0.96
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.12	-0.18	+0.06
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.13	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.04	-0.19	+0.14

Drawdowns

SMTI vs. BVS - Drawdown Comparison

The maximum SMTI drawdown since its inception was -97.48%, roughly equal to the maximum BVS drawdown of -95.18%. Use the drawdown chart below to compare losses from any high point for SMTI and BVS.

Drawdown Indicators

	SMTI	BVS	Difference
Max Drawdown Largest peak-to-trough decline	-97.48%	-95.18%	-2.30%
Max Drawdown (1Y) Largest decline over 1 year	-54.29%	-27.51%	-26.78%
Max Drawdown (3Y) Largest decline over 3 years	-64.47%	-55.22%	-9.25%
Max Drawdown (5Y) Largest decline over 5 years	-67.11%	-95.07%	+27.96%
Max Drawdown (10Y) Largest decline over 10 years	-81.82%	—	—
Current Drawdown Current decline from peak	-73.26%	-57.78%	-15.48%
Average Drawdown Average peak-to-trough decline	-75.24%	-56.39%	-18.85%
Ulcer Index Depth and duration of drawdowns from previous peaks	32.26%	7.37%	+24.89%

Volatility

SMTI vs. BVS - Volatility Comparison

Sanara MedTech Inc. (SMTI) and Bioventus Inc. (BVS) have volatilities of 18.37% and 18.59%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SMTI	BVS	Difference
Volatility (1M) Calculated over the trailing 1-month period	18.37%	18.59%	-0.22%
Volatility (6M) Calculated over the trailing 6-month period	39.80%	32.52%	+7.28%
Volatility (1Y) Calculated over the trailing 1-year period	61.15%	50.31%	+10.84%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	56.55%	81.01%	-24.46%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	112.15%	80.08%	+32.07%

Dividends

SMTI vs. BVS - Dividend Comparison

Neither SMTI nor BVS has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

SMTI vs. BVS - Profitability Comparison

The chart below illustrates the profitability comparison between Sanara MedTech Inc. and Bioventus Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

SMTI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Sanara MedTech Inc. reported a gross profit of 25.87M and revenue of 27.80M. Therefore, the gross margin over that period was 93.1%.

BVS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Bioventus Inc. reported a gross profit of 90.77M and revenue of 132.09M. Therefore, the gross margin over that period was 68.7%.

SMTI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Sanara MedTech Inc. reported an operating income of 2.65M and revenue of 27.80M, resulting in an operating margin of 9.5%.

BVS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Bioventus Inc. reported an operating income of 8.42M and revenue of 132.09M, resulting in an operating margin of 6.4%.

SMTI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Sanara MedTech Inc. reported a net income of 458.96K and revenue of 27.80M, resulting in a net margin of 1.7%.

BVS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Bioventus Inc. reported a net income of 3.11M and revenue of 132.09M, resulting in a net margin of 2.4%.

Frequently Asked Questions

Can I hold both SMTI and BVS in my portfolio?

SMTI and BVS have a correlation of 0.42, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, SMTI or BVS?

BVS has higher volatility (18.59%) compared to SMTI (18.37%). In terms of maximum drawdown, SMTI dropped -97.48% vs BVS's -95.18%.

Which has better risk-adjusted returns?

BVS currently has the higher Sharpe Ratio (0.52 vs -0.44), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.